Intersect ENT, Inc.·4

Jan 3, 8:11 PM ET

Stimson Susan P 4

4 · Intersect ENT, Inc. · Filed Jan 3, 2019

Insider Transaction Report

Form 4
Period: 2018-12-31
Stimson Susan P
Vice President, Marketing
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-12-315,0005,938 total
    Exercise: $1.20Exp: 2023-04-22Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2018-12-31$1.20/sh+5,000$6,00041,703 total
Footnotes (2)
  • [F1]Includes 8,033 Restricted Stock Units.
  • [F2]The shares subject to the option vest monthly over four years commencing April 23, 2013.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT